Recently, the Class 1.1 innovative traditional Chinese medicine (TCM) Qifang Bitong Tablets of Beijing Yiling Pharmaceutical Co., Ltd. is approved for marketing by China NMPA.

This product is designed to strengthen Qi and unblock the orifices. It is indicated for the treatment of persistent allergic rhinitis with lung and spleen deficiency in patients not complicated by seasonal allergens, and is effective in alleviating symptoms such as sneezing, runny nose, itching, and nasal congestion. The typical clinical presentation includes a pale tongue, white coating, and a floating or weak pulse. This approval provides a new treatment option for patients with non-seasonal persistent allergic rhinitis.